The life-cycle of pharmaceuticals in the environment / (Record no. 1601)

MARC details
000 -LEADER
fixed length control field 07034cam a22007211i 4500
001 - CONTROL NUMBER
control field 022506692
003 - CONTROL NUMBER IDENTIFIER
control field UkOxU
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20230116112527.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cnu---unuuu
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 151118s2016 ne ob 001 0 eng d
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
LC control number 2015934369
015 ## - NATIONAL BIBLIOGRAPHY NUMBER
National bibliography number GBB572048
Source bnb
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER
Record control number 017382831
Source Uk
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781907568251
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9781907568251
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)929851505
Canceled/invalid control number (OCoLC)930760179
-- (OCoLC)932062918
-- (OCoLC)936865349
-- (OCoLC)961888187
-- (OCoLC)968978821
-- (OCoLC)988617164
-- (OCoLC)990762874
-- (OCoLC)999484913
-- (OCoLC)1066559818
-- (OCoLC)1088964678
-- (OCoLC)1228552658
040 ## - CATALOGING SOURCE
Original cataloging agency N$T
Language of cataloging eng
Description conventions rda
-- pn
Transcribing agency N$T
Modifying agency IDEBK
-- N$T
-- YDXCP
-- OPELS
-- KNOVL
-- COO
-- VT2
-- UAB
-- OCLCO
-- OCLCQ
-- OCLCA
-- U3W
-- REB
-- D6H
-- OCLCF
-- OCLCO
-- OCLCQ
-- ZCU
-- OCLCO
-- CEF
-- RRP
-- AU@
-- OCLCO
-- WYU
-- OCLCA
-- LOA
-- OCLCQ
-- OCLCO
-- USU
-- OCLCO
-- COCUF
-- OCLCO
-- NLE
-- EBLCP
-- CUY
-- MERUC
-- ICG
-- DKC
-- LIP
-- FEM
-- UKMGB
-- OCLCQ
-- OCLCA
-- MM9
-- GSU
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number TD196.D78
Item number PEA
060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number 2016 D-347
060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number WA 689
072 #7 - SUBJECT CATEGORY CODE
Subject category code BUS
Subject category code subdivision 032000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code SOC
Subject category code subdivision 000000
Source bisacsh
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 363.738
Edition number 23
092 ## - LOCALLY ASSIGNED DEWEY CALL NUMBER (OCLC)
Classification number WMS929851505
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Peake, B. M.,
Relator term author.
245 14 - TITLE STATEMENT
Title The life-cycle of pharmaceuticals in the environment /
Statement of responsibility, etc. Barrie M. Peake, Rhiannon Braund, Alfred Y.C. Tong, Louis A. Tremblay.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Amsterdam :
Name of producer, publisher, distributor, manufacturer Elsevier,
Date of production, publication, distribution, manufacture, or copyright notice 2016.
300 ## - PHYSICAL DESCRIPTION
Extent xi, 258 pages :
Dimensions 24 cm.
Other physical details illustrations ;
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term unmediated
Media type code u
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term volume
Carrier type code un
Source rdacarrier
347 ## - DIGITAL FILE CHARACTERISTICS
File type text file
Source rda
490 1# - SERIES STATEMENT
Series statement Woodhead Publishing series in biomedicine,
International Standard Serial Number 2050-0289 ;
Volume/sequential designation number 51
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc. note Includes bibliographical references and index.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Front Cover; The Life-Cycle of Pharmaceuticals in the Environment; Copyright; Dedication; Contents; Foreword; Acknowledgements; Chapter 1: Introduction; 1.1 Overview: Do pharmaceuticals pose a significant environmental risk?; 1.2 Hazardous substances; 1.3 Pathways to the environment: Life-cycle of pharmaceuticals; 1.4 Conclusions; References; Chapter 2: Prescribing practices; 2.1 Pharmaceuticals in legislative and healthcare systems; 2.1.1 Case study: the role of PHARMAC in New Zealand pharmaceutical expenditure; 2.2 The role of patient medical adherence.
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 2.2.1 Secondary nonadherence and conscientiousness2.2.2 Secondary nonadherence and medication-information seeking behavior; 2.2.3 "White coat adherence" syndrome; 2.2.4 Secondary nonadherence and adverse drug reactions, side effects, or efficacy; 2.2.5 Secondary nonadherence and complex dosing regimens; 2.3 Strategies to minimize medication nonadherence; 2.4 "Doctor, it just doesn't work!"-Pharmacodynamics, pharmacokinetics, and pharmaceutical waste; 2.4.1 Action and behavior of drugs; 2.4.2 Patient medical history; 2.4.3 Concomitant medications; 2.4.4 Dose titrations.
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 2.5 "How much are those antibiotics? I want'em!"2.6 Accumulation of unused medications; 2.6.1 Return of unused medications to pharmacies and general medical practices; 2.7 Strategies to prevent accumulation of unused pharmaceuticals; References; Chapter 3: Disposal of unused medications; 3.1 Overview; 3.2 The origins of unused medication; 3.3 Medication disposal by households; 3.4 Attitudes toward medication disposal; 3.4.1 Influence of dosage form design; 3.4.2 Medication disposal methods and environmental awareness; 3.4.3 Medication disposal and advice received.
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 3.4.4 Medication disposal practices and demographics3.4.5 Availability of formalized protocols for unused medication disposal; 3.5 Feasibility of take-back programmes for unused medication; 3.6 Management of pharmaceutical waste at take-back depots; 3.7 The "best" method for the disposal of unused medications?; 3.8 Conclusions; References; Chapter 4: Detection and presence of pharmaceuticals in the environment; 4.1 Overview; 4.2 Environmental detection of pharmaceuticals; 4.3 Sample collection; 4.3.1 To silanize or not to silanize-that is the sample container.
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 4.3.2 Modes and frequency of sampling4.3.3 Sample storage conditions and preservation techniques; 4.3.4 Sample filtration; 4.4 Sample extraction; 4.4.1 Solid-phase extraction; 4.4.2 Liquid-liquid extraction; 4.5 Chromatographic separation of environmental sample extracts; 4.6 Mass spectrometric detection and quantitation; 4.6.1 Forms of output from LC-MS/MS; 4.6.2 Identification and quantification of an analyte; 4.6.3 Limits of detection; 4.6.4 Extraction recovery efficiency and matrix effect; 4.7 Environmental concentrations of some common pharmaceuticals; 4.8 Summary; References.
520 ## - SUMMARY, ETC.
Summary, etc. The Life-Cycle of Pharmaceuticals in the Environment identifies pathways of entry of pharmaceuticals into the environment, beginning with the role of global prescribing and disposal practices. The book then discusses typical levels of common pharmaceuticals and how they can be determined in natural waters such as raw and treated sewage, and in potable water. In addition, sections examine methods currently available to degrade pharmaceuticals in natural waters and some of their ecotoxicological impacts, along with future considerations and the growing concept of product stewardship. Encompasses the full lifecycle of common pharmaceuticals, from prescription and dispensing practices to their occurrence in a range of different types of natural waters and their environmental impact Explores the role of the healthcare system and its affect on users Beneficial for environmental engineers involved in the design and operation of appropriate degradation technologies of the pharmaceutical prescription and disposal practices.
546 ## - LANGUAGE NOTE
Language note English.
588 0# - SOURCE OF DESCRIPTION NOTE
Source of description note Online resource; title from PDF title page (EBSCO, viewed November 25, 2015).
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drugs
General subdivision Environmental aspects.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drugs
General subdivision Biodegradation.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Decomposition (Chemistry)
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Water Pollution, Chemical
General subdivision analysis.
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmaceutical Preparations
General subdivision analysis.
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Water Pollution, Chemical
General subdivision prevention & control.
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Environmental Pollutants
General subdivision adverse effects.
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Environmental Monitoring
General subdivision methods.
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element BUSINESS & ECONOMICS
General subdivision Infrastructure.
Source of heading or term bisacsh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element SOCIAL SCIENCE
General subdivision General.
Source of heading or term bisacsh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Decomposition (Chemistry)
Source of heading or term fast
Authority record control number or standard number (OCoLC)fst00889125
655 #0 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic book.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Braund, Rhiannon,
Relator term author.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tong, Alfred Y. C.,
Relator term author.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tremblay, Louis A.,
Relator term author.
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Print version:
Title Life-cycle of pharmaceuticals in the environment.
Place, publisher, and date of publication Amsterdam, Netherlands : Elsevier, ©2016
Physical description x, 258 pages
Series data for related item Woodhead Publishing series in biomedicine ; Number 51
International Standard Book Number 9781907568251
Record control number (DLC) 2015934369
-- (OCoLC)950696302
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Woodhead Publishing series in biomedicine ;
Volume/sequential designation no. 51.
International Standard Serial Number 2050-0289
856 40 - ELECTRONIC LOCATION AND ACCESS
Materials specified ScienceDirect All Books
Uniform Resource Identifier <a href="https://www.sciencedirect.com/science/book/9781907568251">https://www.sciencedirect.com/science/book/9781907568251</a>
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Library of Congress Classification
Koha item type Books
Suppress in OPAC No
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Collection code Home library Current library Shelving location Date acquired Source of acquisition Inventory number Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
    Library of Congress Classification     Non-fiction GSU Library Epoch GSU Library Epoch General Stacks 20/12/2022 BAI 04094   TD196.D78PEA 50000005319 16/01/2023 16/01/2023 Books